Search Ontology:
ChEBI

amikacin

Term ID
CHEBI:2637
Synonyms
  • (2S)-4-amino-N-[(1R,2S,3S,4R,5S)-5-amino-2-(3-amino-3-deoxy-alpha-D-glucopyranosyloxy)-4-(6-amino-6-deoxy-alpha-D-glucopyranosyloxy)-3-hydroxycyclohexyl]-2-hydroxybutanamide
  • 1-N-(L(-)-gamma-amino-alpha-hydroxybutyryl)kanamycin A
  • Amikacin
  • amikacina
  • amikacine
  • amikacinum
  • O-3-amino-3-deoxy-alpha-D-glucopyranosyl-(1->4)-O-(6-amino-6-deoxy-alpha-D-glucopyranosyl-(1->6))-N(3)-(4-amino-L-2-hydroxybutyryl)-2-deoxy-L-streptamine
Definition
An amino cyclitol glycoside that is kanamycin A acylated at the N-1 position by a 4-amino-2-hydroxybutyryl group.
References
  • cas:37517-28-5
  • drugbank:DB00479
  • drugcentral:157
  • hmdb:HMDB0014622
  • kegg.compound:C06820
  • kegg.drug:D02543
  • lincs.smallmolecule:LSM-5935
  • metacyc.compound:CPD-14197
  • patent:DE2234315
  • patent:US3781268
  • pubmed:11744283
  • pubmed:15305513
  • pubmed:17365906
  • pubmed:19495517
  • pubmed:19752274
  • pubmed:20195673
  • pubmed:25296102
  • pubmed:25327505
  • pubmed:25339395
  • pubmed:25630642
  • pubmed:8622103
  • pubmed:8622117
  • pubmed:9327246
  • reaxys:5915117
  • wikipedia.en:Amikacin
Ontology
ChEBI  ( EBI )
Resources
CTD
Relationships
Phenotype
Phenotype resulting from amikacin
Phenotype where environments contain amikacin
Phenotype modified by environments containing amikacin
Phenotype affecting amikacin
Human Disease Model